Effect of quercetin on paraoxonase 1 activity--studies in cultured cells, mice and humans.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 20228421)

Published in J Physiol Pharmacol on February 01, 2010

Authors

C Boesch-Saadatmandi1, S Egert, C Schrader, X Coumoul, X Coumol, R Barouki, M J Muller, S Wolffram, G Rimbach

Author Affiliations

1: Institute of Human Nutrition and Food Science, Christian Albrechts University Kiel, Kiel, Germany.

Articles citing this

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochem Pharmacol (2010) 1.14

Which sources of flavonoids: complex diets or dietary supplements? Adv Nutr (2011) 0.99

The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal (2011) 0.95

Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease. Pharmacogenomics (2013) 0.91

Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. J Nutr Biochem (2014) 0.89

Genistein as a potential inducer of the anti-atherogenic enzyme paraoxonase-1: studies in cultured hepatocytes in vitro and in rat liver in vivo. J Cell Mol Med (2012) 0.78

Free Radical Scavenging and Cellular Antioxidant Properties of Astaxanthin. Int J Mol Sci (2016) 0.77

Regiospecific methylation of a dietary flavonoid scaffold selectively enhances IL-1β production following Toll-like receptor 2 stimulation in THP-1 monocytes. J Biol Chem (2013) 0.77

Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling. Inflammation (2016) 0.76

Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans. Eur J Nutr (2015) 0.75

Effects of Dietary Flavonoids on Reverse Cholesterol Transport, HDL Metabolism, and HDL Function. Adv Nutr (2017) 0.75

Articles by these authors

Alcoholism: a controlled trial of "treatment" and "advice". J Stud Alcohol (1977) 4.14

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst (1998) 3.67

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer (1999) 2.68

The Amsterdam Preoperative Anxiety and Information Scale (APAIS) Anesth Analg (1996) 2.33

The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer (2005) 2.09

[Less use of alternative treatments by cancer patients in 2002 than in 1999]. Ned Tijdschr Geneeskd (2003) 1.99

Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol (1996) 1.95

Self-reported coping behavior of wives of alcoholics and its association with drinking outcome. J Stud Alcohol (1975) 1.91

Repression of gene expression by oxidative stress. Biochem J (1999) 1.85

Organic compounds from diesel exhaust particles elicit a proinflammatory response in human airway epithelial cells and induce cytochrome p450 1A1 expression. Am J Respir Cell Mol Biol (2001) 1.77

Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition (2001) 1.75

Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr (2001) 1.54

Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology (2002) 1.53

The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol (2000) 1.53

Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med (1999) 1.49

Reexamination of phenotypic defects in rec-1 and rec-2 mutants of Haemophilus influenzae Rd. J Bacteriol (1985) 1.46

Monitoring tissue oxygenation during resuscitation of major burns. J Trauma (2001) 1.44

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol (2002) 1.37

The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care (1997) 1.37

The patient-physician relationship. Patient-physician communication during outpatient palliative treatment visits: an observational study. JAMA (2001) 1.32

The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc Natl Acad Sci U S A (2001) 1.27

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm (Vienna) (2004) 1.26

Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity. Oncogene (2009) 1.24

Voluntary weight loss: systematic review of early phase body composition changes. Obes Rev (2011) 1.23

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol (1998) 1.21

Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost (2004) 1.18

Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18

Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene (2006) 1.18

The cohesiveness of alcoholism-complicated marriages and its influence on treatment outcome. Br J Psychiatry (1976) 1.17

ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc Nutr Soc (2007) 1.14

Ascariasis pneumonitis: a potentially fatal complication in smoke inhalation injury. Burns (1995) 1.10

Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission in rat vas deferens: effects of inhibitors of adenosine uptake and deamination. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.08

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol (2001) 1.06

Parsimony, simplicity and survival in burn care. Burns (2003) 1.05

Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1. J Biol Chem (1998) 1.05

Hormonal discrimination among transcription start sites of aspartate aminotransferase. J Biol Chem (1990) 1.05

Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. Biopharm Drug Dispos (2003) 1.03

Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway. Toxicol Lett (1998) 1.03

In vitro biosynthesis and membrane insertion of gamma-glutamyl transpeptidase. J Biol Chem (1984) 1.02

Relaxant effects of forskolin in smooth muscle. Role of cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.02

Biosynthesis and processing of gamma-glutamyl transpeptidase in hepatoma tissue culture cells. J Biol Chem (1984) 1.01

The isolation of a bluetongue virus from Culicoides collected in the Northern Territory of Australia. Aust Vet J (1978) 0.99

Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol (2001) 0.99

Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands. Eur J Cancer (2006) 0.99

Nutritional significance of phytic acid and phytase. Arch Tierernahr (1997) 0.98

An autoregulatory loop controlling CYP1A1 gene expression: role of H(2)O(2) and NFI. Mol Cell Biol (1999) 0.98

Adrenergic regulation of glycogenolysis in rat liver after cholestasis. Modulation of the balance between alpha 1 and beta 2 receptors. J Clin Invest (1983) 0.98

Apamin, a nonspecific antagonist of smooth muscle relaxants. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.97

Tissue-specific expression of two gamma-glutamyl transpeptidase mRNAs with alternative 5' ends encoded by a single copy gene in the rat. J Biol Chem (1990) 0.96

Health-related quality of life among patients with metastatic prostate cancer. Urology (1997) 0.96

Isolation of arboviruses from insects collected at Beatrice Hill, Northern Territory of Australia, 1974-1976. Aust J Biol Sci (1984) 0.96

Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages. FEBS Lett (2000) 0.96

Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. Nutr Metab Cardiovasc Dis (2011) 0.96

Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med (2000) 0.95

Ethanol effects in a rat hepatoma cell line: induction of gamma-glutamyltransferase. Hepatology (1983) 0.95

Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7. Cancer Res (2001) 0.95

2,3,7,8-Tetrachlorodibenzo-p-dioxin induces insulin-like growth factor binding protein-1 gene expression and counteracts the negative effect of insulin. Mol Pharmacol (2004) 0.95

Evidence of lymphangiogenesis in Warthin's tumor of the parotid gland. Oral Oncol (2006) 0.95

A pain monitoring program for nurses: effects on communication, assessment and documentation of patients' pain. J Pain Symptom Manage (2000) 0.94

Initial steps in Haemophilus influenzae transformation. Donor DNA binding in the com10 mutant. J Biol Chem (1986) 0.94

ATP inhibits the synaptic release of acetylcholine in submucosal neurons. J Pharmacol Exp Ther (1995) 0.93

Effect of feeding a high protein diet on amino acid uptake into rat intestinal brush border membrane vesicles. Pflugers Arch (1984) 0.92

Major urinary protein 5, a scent communication protein, is regulated by dietary restriction and subsequent re-feeding in mice. Proc Biol Sci (2013) 0.92

Modulation of human mineralocorticoid receptor function by protein kinase A. Mol Endocrinol (1999) 0.92

CCAAT/enhancer-binding protein-related proteins bind to the unusual promoter of the aspartate aminotransferase housekeeping gene. J Biol Chem (1993) 0.92

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. J Clin Oncol (1996) 0.91

Nucleotide sequence and glucocorticoid regulation of the mRNAs for the isoenzymes of rat aspartate aminotransferase. J Biol Chem (1988) 0.90

Lymphocyte subsets in irradiation-induced sialadenitis of the submandibular gland. Histopathology (2005) 0.90

Rehabilitation of olfaction after laryngectomy by means of a nasal airflow-inducing maneuver: the "polite yawning" technique. Arch Otolaryngol Head Neck Surg (2000) 0.90

Vitamin E supplementation and lifespan in model organisms. Ageing Res Rev (2012) 0.90

Effect of ochratoxin A on redox-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells. Food Chem Toxicol (2008) 0.90

Regulation of the cytosolic aspartate aminotransferase housekeeping gene promoter by glucocorticoids, cAMP, and insulin. Biochemistry (1993) 0.90

[Deep brain stimulation for Parkinson's disease. Consensus recommendations of the German Deep Brain Stimulation Association]. Nervenarzt (2009) 0.89

Translation and validation of the Amsterdam preoperative anxiety and information scale (APAIS) for use in Japan. Qual Life Res (2002) 0.88

The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway. Oncogene (2012) 0.88

Determinants of paraoxonase 1 status: genes, drugs and nutrition. Curr Med Chem (2011) 0.88

Expression of inosine monophosphate dehydrogenase type I and type II after mycophenolate mofetil treatment: a 2-year follow-up in kidney transplantation. Clin Pharmacol Ther (2007) 0.88

Vectors of bluetongue virus in Australia. Prog Clin Biol Res (1985) 0.88

Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radic Biol Med (2001) 0.88

Susceptibility to DYT1 dystonia in European patients is modified by the D216H polymorphism. Neurology (2008) 0.88

Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interleukin-1 production in lipopolysaccharide-stimulated RAW 264.7. Toxicol Appl Pharmacol (2000) 0.87

Regulation of NAD(P)H:quinone oxidoreductase 1 gene expression by CYP1A1 activity. Mol Pharmacol (2004) 0.86

Inconsistencies in bioelectrical impedance and anthropometric measurements of fat mass in a field study of prepubertal children. Br J Nutr (2002) 0.86

Ochratoxin A impairs Nrf2-dependent gene expression in porcine kidney tubulus cells. J Anim Physiol Anim Nutr (Berl) (2008) 0.85

An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis. Eur J Pharmacol (1996) 0.85

Effect of apoE genotype and vitamin E on biomarkers of oxidative stress in cultured neuronal cells and the brain of targeted replacement mice. J Physiol Pharmacol (2007) 0.85

Single center experience of endoscopic submucosal dissection (ESD) in early Barrett's adenocarcinoma. Surg Endosc (2014) 0.85

Characterization of a large population of mRNAs from human testis. Genomics (1995) 0.85

Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett (2001) 0.85

Glucocorticoid hormones increase the activity of gamma-glutamyltransferase in a highly differentiated hepatoma cell line. Biochim Biophys Acta (1982) 0.85

Properties of overlapping EREs: synergistic activation of transcription and cooperative binding of ER. Biochemistry (1998) 0.85

Effect of benzoyl peroxide on antioxidant status, NF-kappaB activity and interleukin-1alpha gene expression in human keratinocytes. Toxicology (2001) 0.84